MAPT (Tau) expression is a biomarker for an increased rate of survival in pediatric neuroblastoma

References

• Spillantini MG, Goedert M. Tau pathology and neurodegeneration. Lancet Neurol. 2013;12:609–622.
   PubMed Web of Science ®Google Scholar
• Buee L, Troquier L, Burnouf S, et al. From tau phosphorylation to tau aggregation: what about neuronal death? Biochem Soc Trans. 2010;38:967–972.
   PubMed Web of Science ®Google Scholar
• Louis CU, Shohet JM. Neuroblastoma: molecular pathogenesis and therapy. Annu Rev Med. 2015;66:49–63.
   PubMed Web of Science ®Google Scholar
• Maris JM, Hogarty MD, Bagatell R, et al. Neuroblastoma. Lancet. 2007;369:2106–2120.
   PubMed Web of Science ®Google Scholar
• Davidoff AM. Neuroblastoma. Semin Pediatr Surg. 2012;21:2–14.
   PubMed Web of Science ®Google Scholar
• Russo R, Cimmino F, Pezone L, et al. Kinome expression profiling of human neuroblastoma tumors identifies potential drug targets for ultra high-risk patients. Carcinogenesis. 2017;38:1011–1020.
   PubMed Web of Science ®Google Scholar
• Saarinen-Pihkala UM, Jahnukainen K, Wikstrom S, et al. Ultrahigh-risk group within the high-risk neuroblastoma category. J Pediatr Hematol Oncol. 2013;35:e254–9.
   PubMed Web of Science ®Google Scholar
• Cohn SL, Pearson AD, London WB, et al. The international neuroblastoma risk group (INRG) classification system: an INRG task force report. J Clin Oncol. 2009;27:289–297.
   PubMed Web of Science ®Google Scholar
• Mauro JA, Blanck G. Functionally distinct gene classes as bigger or smaller transcription factor traps: a possible stochastic component to sequential gene expression programs in cancer. Gene. 2014;536:398–406.
   PubMed Web of Science ®Google Scholar
• Cheng JM, Hiemstra JL, Schneider SS, et al. Preferential amplification of the paternal allele of the N-myc gene in human neuroblastomas. Nat Genet. 1993;4:191–194.
   PubMed Web of Science ®Google Scholar
• Emanuel BS, Balaban G, Boyd JP, et al. N-myc amplification in multiple homogeneously staining regions in two human neuroblastomas. Proc Natl Acad Sci U S A. 1985;82:3736–3740.
   PubMed Web of Science ®Google Scholar
• Brodeur GM, Seeger RC, Schwab M, et al. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science. 1984;224:1121–1124.
   PubMed Web of Science ®Google Scholar
• Borroni B, Bonvicini C, Alberici A, et al. Mutation within TARDBP leads to frontotemporal dementia without motor neuron disease. Hum Mutat. 2009;30:E974–83.
   PubMed Web of Science ®Google Scholar
• Floris G, Borghero G, Cannas A, et al. Clinical phenotypes and radiological findings in frontotemporal dementia related to TARDBP mutations. J Neurol. 2015;262:375–384.
   PubMed Web of Science ®Google Scholar
• Harms MM, Miller TM, Baloh RH. TARDBP-related amyotrophic lateral sclerosis. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. Seattle (WA): GeneReviews((R)); 2009;1993–2018.
   Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30.
   PubMed Web of Science ®Google Scholar
• Ford SA, Blanck G. Signal persistence and amplification in cancer development and possible, related opportunities for novel therapies. Biochim Biophys Acta. 2014;1855:18–23.
   PubMed Web of Science ®Google Scholar
• Kellogg RA, Tay S. Noise facilitates transcriptional control under dynamic inputs. Cell. 2015;160:381–392.
   PubMed Web of Science ®Google Scholar
• Lee YJ, Kim JE, Kwak MH, et al. Selenium treatment significantly inhibits tumor necrosis factor-alpha-induced cell death and tau hyperphosphorylation in neuroblastoma cells. Mol Med Rep. 2014;10:1869–1874.
   PubMed Web of Science ®Google Scholar
• Lee M, McGeer E, McGeer PL. Activated human microglia stimulate neuroblastoma cells to upregulate production of beta amyloid protein and tau: implications for Alzheimer’s disease pathogenesis. Neurobiol Aging. 2015;36:42–52.
   PubMed Web of Science ®Google Scholar
• Petroni D, Tsai J, Agrawal K, et al. Low-dose methylmercury-induced oxidative stress, cytotoxicity, and tau-hyperphosphorylation in human neuroblastoma (SH-SY5Y) cells. Environ Toxicol. 2012;27:549–555.
   PubMed Web of Science ®Google Scholar
• Choi S, Oh JH, Kim H, et al. Protective effect of tat PTD-Hsp27 fusion protein on tau hyperphosphorylation induced by okadaic acid in the human neuroblastoma cell line SH-SY5Y. Cell Mol Neurobiol. 2015;35:1049–1059.
   PubMed Web of Science ®Google Scholar
• Monroy-Ramirez HC, Basurto-Islas G, Mena R, et al. Alterations in the nuclear architecture produced by the overexpression of tau protein in neuroblastoma cells. J Alzheimers Dis. 2013;36:503–520.
   PubMed Web of Science ®Google Scholar
• Ikeda H, Taira N, Hara F, et al. The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells. Breast Cancer Res. 2010;12:R43.
   PubMed Web of Science ®Google Scholar
• Gervais FG, Xu D, Robertson GS, et al. Involvement of caspases in proteolytic cleavage of Alzheimer’s amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell. 1999;97:395–406.
   PubMed Web of Science ®Google Scholar
• Galvan V, Chen S, Lu D, et al. Caspase cleavage of members of the amyloid precursor family of proteins. J Neurochem. 2002;82:283–294.
   PubMed Web of Science ®Google Scholar
• Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by taxol. Nature. 1979;277:665–667.
   PubMed Web of Science ®Google Scholar
• Wiernik PH, Schwartz EL, Strauman JJ, et al. Phase I clinical and pharmacokinetic study of taxol. Cancer Res. 1987;47:2486–2493.
   PubMed Web of Science ®Google Scholar
• Samadi N, Bekele RT, Goping IS, et al. Lysophosphatidate induces chemo-resistance by releasing breast cancer cells from taxol-induced mitotic arrest. PloS one. 2011;6:e20608.
   PubMed Web of Science ®Google Scholar
• Snyder JP, Nettles JH, Cornett B, et al. The binding conformation of Taxol in beta-tubulin: a model based on electron crystallographic density. Proc Natl Acad Sci U S A. 2001;98:5312–5316.
   PubMed Web of Science ®Google Scholar
• Arnal I, Wade RH. How does taxol stabilize microtubules? Current Biology: CB. 1995;5:900–908.
   PubMed Web of Science ®Google Scholar
• Bouge AL, Parmentier ML. Tau excess impairs mitosis and kinesin-5 function, leading to aneuploidy and cell death. Dis Model Mech. 2016;9:307–319.
   PubMed Web of Science ®Google Scholar
• Akinrinmade OA, Jordaan S, Hristodorov D, et al. Human MAP tau based targeted cytolytic fusion proteins. Biomedicines. 2017;5:36.
   Web of Science ®Google Scholar
• Wu JM, DiPietrantonio AM, Hsieh TC. Mechanism of fenretinide (4-HPR)-induced cell death. Apoptosis. 2001;6:377–388.
   PubMed Web of Science ®Google Scholar
• Jazvinscak Jembrek M, Hof PR, Simic G. Ceramides in Alzheimer’s disease: key mediators of neuronal apoptosis induced by oxidative stress and abeta accumulation. Oxid Med Cell Longev. 2015;2015:346783.
   PubMed Web of Science ®Google Scholar
• Mielke MM, Haughey NJ, Bandaru VVR, et al. Cerebrospinal fluid sphingolipids, beta-amyloid, and tau in adults at risk for Alzheimer’s disease. Neurobiol Aging. 2014;35:2486–2494.
   PubMed Web of Science ®Google Scholar